Vericel Corp Ord (VCEL)

Exchange
NASDAQ
Symbol
VCEL
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: May 30, 2025

  • Open
    41.27
  • High
    42.12
  • Low
    40.54
  • Close
    41.30
  • Volume
    715,515

Financial ratios

Dec 31, 2024